Medical research safety stands at the forefront of ethical scientific practices, ensuring that the welfare of patients involved in studies is prioritized.With the challenges posed by funding cuts, particularly the recent halt of over $2 billion in federal research grants, the delicate balance of maintaining adequate IRB oversight is increasingly jeopardized.